Abtrace
1 known investors
Abtrace is a proactive monitoring and intelligent recall tool for NHS primary care that reads a practice's clinical record daily to find patients due or overdue for tests, reviews or vaccinations, and automates recall, self-booking, SNOMED coding correction and drug monitoring. It integrates with EMIS Web and TPP SystmOne and is used by GPs, pharmacists, nurses, HCAs and administrators across practices, PCNs and ICBs in England.</parameter> <parameter name="founders">[]
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- ABTRACE LIMITED
- Company number
- 11535661
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 24 Aug 2018
- Registered office
- 6th Floor, Manfield House, 1 Southampton Street, London, WC2R 0LR
- Nature of business (SIC)
- 62090 — Other information technology service activities
- Accounts
- last made up to 31 Aug 2025 · next due 31 May 2027
- Confirmation statement
- last made up to 21 Aug 2025 · next due 4 Sept 2026
Current officers · 3
- Umar Naeem Ahmad — director, appointed 24 Aug 2018
- Cristina Correia — director, appointed 24 Aug 2018
- Helder Tão Ferraz Cardoso Soares — director, appointed 24 Aug 2018
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Abtrace do?
- Abtrace is a proactive monitoring and intelligent recall tool for NHS primary care that reads a practice's clinical record daily to find patients due or overdue for tests, reviews or vaccinations, and automates recall, self-booking, SNOMED coding correction and drug monitoring. It integrates with EMIS Web and TPP SystmOne and is used by GPs, pharmacists, nurses, HCAs and administrators across practices, PCNs and ICBs in England.</parameter> <parameter name="founders">[]
- Who are Abtrace's investors?
- Abtrace's investors include Faber.